← Leaderboards
Susan Hintz
Children'S Hosp Of Philadelphia
$556,797
Attributed
$2,227,186
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $532.8K · FY2017–23$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,227,186 · 2
By mechanism
UH3$1,907,779 · 1
UG3$319,407 · 1
Top collaborators
- Sara Bonamo Demauro8 shared
- Suhas Kallapur8 shared
- Haresh Kirpalani8 shared
Most similar at Children'S Hosp Of Philadelphia
Same institution · by research overlap
- Sara Bonamo Demauro$17,178,971
- Erik Allen Jensen$3,441,542
- Frederic D Bushman$38,686,561
- Stephen Paridon$1,749,233
- James William Gaynor$5,405,569
Others in their field
Other Emerging Leaders on “Follow-Up Studies”
- Leonard Freedman · Leidos Biomedical Research, Inc.$100,435,783
- Dale Sandler · Social And Scientific Systems, Inc.$41,380,317
- Paula Gonzalez-Maya · Fundacion Inciensa$37,578,679
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$26,317,404
- Tharick Pascoal · University Of Pittsburgh At Pittsburgh$25,068,887
- Badri N Vardarajan · University Of Miami School Of Medicine$23,638,161
Research focus
Follow-Up Studies5 Year OldFailureFollow-UpBronchopulmonary DysplasiaBudgetsAffectChildExposure ToClinical TrialsCognitiveCohortCollaborationsConsensusCounselingData Coordinating CenterDevelopmental Coordination DisordersEconomic OutcomeBehaviorEnrollmentEnsureEvaluationExercise CapacityFunctional Disability
Grant awards (8)
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center$246,511
UH3 · FY2023 · HL
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center$264,047
UH3 · FY2022 · HL
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center$266,409
UH3 · FY2021 · HL
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center$266,409
UH3 · FY2020 · HL
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center$266,409
UH3 · FY2020 · HL
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center$275,728
UH3 · FY2019 · HL
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center$322,266
UH3 · FY2018 · HL
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center$319,407
UG3 · FY2017 · HL